X4 Pharmaceuticals, Inc. (XFOR)

X4 Pharmaceuticals Statistics

Total Valuation

XFOR has a market cap or net worth of $62.28 million. The enterprise value is $6.50 million.

Market Cap	62.28M
Enterprise Value	6.50M

Important Dates

The last earnings date was Wednesday, November 13, 2024, before market open.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

XFOR has 170.55 million shares outstanding. The number of shares has increased by 30.46% in one year.

Current Share Class	170.55M
Shares Outstanding	170.55M
Shares Change (YoY)	+30.46%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	5.12%
Owned by Institutions (%)	46.69%
Float	129.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	66.11
Forward PS	5.56
PB Ratio	1.05
P/TBV Ratio	1.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.79
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.89, with a Debt / Equity ratio of 1.31.

Current Ratio	4.89
Quick Ratio	4.65
Debt / Equity	1.31
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-15.67

Financial Efficiency

Return on equity (ROE) is -26.35% and return on invested capital (ROIC) is -62.04%.

Return on Equity (ROE)	-26.35%
Return on Assets (ROA)	-46.55%
Return on Capital (ROIC)	-62.04%
Revenue Per Employee	$12,075
Profits Per Employee	-$180,204
Employee Count	93
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, XFOR has paid $85,000 in taxes.

Income Tax	85,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.08% in the last 52 weeks. The beta is 0.34, so XFOR's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	-51.08%
50-Day Moving Average	0.51
200-Day Moving Average	0.82
Relative Strength Index (RSI)	40.91
Average Volume (20 Days)	5,333,487

Short Selling Information

The latest short interest is 12.94 million, so 7.59% of the outstanding shares have been sold short.

Short Interest	12.94M
Short Previous Month	11.42M
Short % of Shares Out	7.59%
Short % of Float	9.96%
Short Ratio (days to cover)	8.64

Income Statement

In the last 12 months, XFOR had revenue of $1.12 million and -$16.76 million in losses. Loss per share was -$0.09.

Revenue	1.12M
Gross Profit	628,000
Operating Income	-130.89M
Pretax Income	17.73M
Net Income	-16.76M
EBITDA	-130.30M
EBIT	-130.89M
Loss Per Share	-$0.09

Balance Sheet

The company has $134.98 million in cash and $78.20 million in debt, giving a net cash position of $56.77 million or $0.33 per share.

Cash & Cash Equivalents	134.98M
Total Debt	78.20M
Net Cash	56.77M
Net Cash Per Share	$0.33
Equity (Book Value)	59.62M
Book Value Per Share	0.35
Working Capital	113.71M

Cash Flow

In the last 12 months, operating cash flow was -$125.65 million and capital expenditures -$320,000, giving a free cash flow of -$125.97 million.

Operating Cash Flow	-125.65M
Capital Expenditures	-320,000
Free Cash Flow	-125.97M
FCF Per Share	-$0.74

Margins

Gross Margin	55.92%
Operating Margin	-11,654.94%
Pretax Margin	-1,484.77%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-21,258.44%

Dividends & Yields

XFOR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.46%
Shareholder Yield	-30.46%
Earnings Yield	-26.49%
FCF Yield	-199.10%

Analyst Forecast

The average price target for XFOR is $2.88, which is 688.61% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.88
Price Target Difference	688.61%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XFOR has an Altman Z-Score of -4.64. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.64
Piotroski F-Score	n/a